Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma

被引：0

作者：

Demir, Tarik ^{[1
]}

Moloney, Carolyn ^{[1
]}

Mahalingam, Devalingam ^{[1
]}

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Dev Therapeut, Feinberg Sch Med, Chicago, IL 60611 USA

来源：

CANCERS | 2025年 / 17卷 / 05期

关键词：

biomarkers; immunology; immunotherapy; pancreas adenocarcinoma; resistance mechanisms; MISMATCH REPAIR DEFICIENCY; REGULATORY T-CELLS; HLA-DR EXPRESSION; TUMOR DNA CTDNA; IFN-GAMMA; SOLID TUMORS; PHASE-I; MONOCLONAL-ANTIBODY; PEPTIDE VACCINATION; PARP INHIBITION;

D O I：

10.3390/cancers17050715

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with a poor prognosis. Currently, chemotherapy is the only option for most patients with advanced-stage PDAC. Further, conventional immunotherapies and targeted therapies improve survival outcomes only in rare PDAC patient subgroups. To date, combinatory immunotherapeutic strategies to overcome the immune-hostile PDAC tumor microenvironment (TME) have resulted in limited efficacy in clinical studies. However, efforts are ongoing to develop new treatment strategies for patients with PDAC with the evolving knowledge of the TME, molecular characterization, and immune resistance mechanisms. Further, the growing arsenal of various immunotherapeutic agents, including novel classes of immune checkpoint inhibitors and oncolytic, chimeric antigen receptor T cell, and vaccine therapies, reinforces these efforts. This review will focus on the place of immunotherapy and future possible strategies in PDAC.

引用

页数：42

共 256 条

[101] STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models [J].

Jing, Weiqing ;

McAllister, Donna ;

Vonderhaar, Emily P. ;

Palen, Katie ;

Riese, Matthew J. ;

Gershan, Jill ;

Johnson, Bryon D. ;

Dwinell, Michael B. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7

[102] Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy [J].

Johnson, Douglas B. ;

Estrada, Monica V. ;

Salgado, Roberto ;

Sanchez, Violeta ;

Doxie, Deon B. ;

Opalenik, Susan R. ;

Vilgelm, Anna E. ;

Feld, Emily ;

Johnson, Adam S. ;

Greenplate, Allison R. ;

Sanders, Melinda E. ;

Lovly, Christine M. ;

Frederick, Dennie T. ;

Kelley, Mark C. ;

Richmond, Ann ;

Irish, Jonathan M. ;

Shyr, Yu ;

Sullivan, Ryan J. ;

Puzanov, Igor ;

Sosman, Jeffrey A. ;

Balko, Justin M. .

NATURE COMMUNICATIONS, 2016, 7

[103] Glycogen Synthase Kinase-3β Indirectly Facilitates Interferon-γ-Induced Nuclear Factor-κB Activation and Nitric Oxide Biosynthesis [J].

Kai, Jui-In ;

Huang, Wei-Ching ;

Tsai, Cheng-Chieh ;

Chang, Wen-Teng ;

Chen, Chia-Ling ;

Lin, Chiou-Feng .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 111 (06) :1522-1530

[104] Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study [J].

Kamath, Suneel D. ;

Kalyan, Aparna ;

Kircher, Sheetal ;

Nimeiri, Halla ;

Fought, Angela J. ;

Benson, Al, III ;

Mulcahy, Mary .

ONCOLOGIST, 2020, 25 (05) :E808-E815

[105] Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes [J].

Kanterman, Julia ;

Sade-Feldman, Moshe ;

Biton, Moshe ;

Ish-Shalom, Eliran ;

Lasry, Audrey ;

Goldshtein, Aviya ;

Hubert, Ayala ;

Baniyash, Michal .

CANCER RESEARCH, 2014, 74 (21) :6022-6035

[106] PD-1/PD-L1-Associated Immunoarchitectural Patterns Stratify Pancreatic Cancer Patients into Prognostic/ Predictive Subgroups [J].

Karamitopoulou, Eva ;

Andreou, Andreas ;

de Mortanges, Aurelie Pahud ;

Tinguely, Marianne ;

Gloor, Beat ;

Perren, Aurel .

CANCER IMMUNOLOGY RESEARCH, 2021, 9 (12) :1439-1450

[107] A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy [J].

Katsuda, Masahiro ;

Miyazawa, Motoki ;

Ojima, Toshiyasu ;

Katanuma, Akio ;

Hakamada, Kenichi ;

Sudo, Kentaro ;

Asahara, Shingo ;

Endo, Itaru ;

Ueno, Makoto ;

Hara, Kazuo ;

Yamada, Suguru ;

Fujii, Tsutomu ;

Satoi, Sohei ;

Ioka, Tatsuya ;

Ohira, Masaichi ;

Akahori, Takahiro ;

Kitano, Masayuki ;

Nagano, Hiroaki ;

Furukawa, Masayuki ;

Adachi, Tomohiko ;

Yamaue, Hiroki .

TRIALS, 2019, 20 (1)

[108] Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival [J].

Kavan, Petr ;

Saltzman, Daniel A. ;

Muegge, Jule ;

Moradian, Jordan ;

Batist, Gerald .

CANCER RESEARCH, 2023, 83 (08)

[109]

Khattak A., 2023, CANCER RES, V83, pCT001, DOI [10.1158/1538-7445.AM2023-CT001, DOI 10.1158/1538-7445.AM2023-CT001]

[110] GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia [J].

Kim-Muller, Ja Young ;

Song, LouJin ;

Paulhus, Brianna LaCarubba ;

Pashos, Evanthia ;

Li, Xiangping ;

Rinaldi, Anthony ;

Joaquim, Stephanie ;

Stansfield, John C. ;

Zhang, Jiangwei ;

Robertson, Andrew ;

Pang, Jincheng ;

Opsahl, Alan ;

Boucher, Magalie ;

Breen, Danna ;

Hales, Katherine ;

Sheikh, Abdul ;

Wu, Zhidan ;

Zhang, Bei B. .

CELL REPORTS, 2023, 42 (01)

← 6 7 8 9 10 11 12 13 14 15 →